MDLN — Medline Cashflow Statement
0.000.00%
Last trade - 00:00- $48.08bn
- $65.48bn
- $28.43bn
Annual cashflow statement for Medline, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 234 | 1,200 | 1,157 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 325 | 291 | 359 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 199 | -675 | -783 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 1,685 | 1,769 | 1,744 |
| Capital Expenditures | -275 | -354 | -447 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -37 | -1,139 | -27 |
| Acquisition of Business | |||
| Sale of Business | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -312 | -1,493 | -474 |
| Financing Cash Flow Items | -114 | -1,530 | -554 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -191 | -1,613 | 399 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 1,186 | -1,335 | 1,692 |